PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
08-Mar-2024 Accumulus Synergy Adds Two World-Class Executives to Its Leadership Team Accumulus Synergy, Inc.
08-Mar-2024 US FDA grants Orphan Drug Designation for iOnctura’s first-in-class autotaxin cancer therapy iOnctura
07-Mar-2024 Phastar Vice President Prof Jennifer Visser-Rogers Named in Women in Data® Twenty in Data & Technology Phastar
06-Mar-2024 Ellipses’ next generation selective RET inhibitor EP0031/A400 granted Fast Track designation by US Food and Drug Administration Ellipses Pharma
06-Mar-2024 Semantic Data 2024: Taxonomy, Ontology and, Knowledge Graphs - First Speakers Announced Henry Stewart Events
06-Mar-2024 Zenas BioPharma Appoints Patricia Allen to its Board of Directors Zenas BioPharma
06-Mar-2024 iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors iTeos Therapeutics, Inc.
06-Mar-2024 Asceneuron Expands Scientific Advisory Board with World Leading Experts in Neurodegenerative Diseases Asceneuron
06-Mar-2024 Women in Life Science Denmark (WiLD) to host network meeting in collaboration with DANISH BIO to promote equity in the Danish life science industry Women in Life Science Denmark (WiLD)
06-Mar-2024 FDA Clears Beckman Coulter Life Sciences DxFLEX Flow Cytometer Beckman Coulter Life Sciences
06-Mar-2024 Jemperli▼ (dostarlimab) becomes the first immunotherapy treatment to receive NICE recommendation for use, in line with its license, in eligible endometrial cancer patients in first line setting GSK
05-Mar-2024 ADARE PHARMA SOLUTIONS TO EXPAND PACKAGING & WAREHOUSING CAPABILITIES IN EUROPE Adare Pharma Solutions
05-Mar-2024 The York Health Economic Consortium will undertake the first UK health economic analysis of Ondine’s Steriwave light-activated antimicrobial to reduce Surgical Site Infections York Health Economics Consortium (YHEC)
05-Mar-2024 Ariceum Therapeutics announces opening of new state-of-the-art laboratory in Berlin providing infrastructure for radiopharmaceutical development activities Ariceum Therapeutics
05-Mar-2024 Fibrocor Therapeutics enters into research and development collaboration with McQuade Center for Strategic Research and Development to advance Alport Syndrome program Fibrocor Therapeutics Inc
05-Mar-2024 Alcidion launches Miya Results Tracking in response to patient safety challenge Alcidion Group Limited
05-Mar-2024 Transgene, NEC and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050 Transgene
05-Mar-2024 Lundbeck presents encouraging results from the Lu AF82422 trial for Multiple System Atrophy at the international AD/PD 2024 conference on neurodegenerative disorders Lundbeck A/S
05-Mar-2024 ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses ViiV Healthcare
05-Mar-2024 CluePoints’ Audit Trail Review Project Wins Award for Innovation in the Management of Clinical Data Award CluePoints